Amarin Corp Plc (AMRN)

[KCSVEN]

Insider sales from after approval have zero bearing on what management thinks of drug and launch. If they thought negative on drug they would not hold onto 95% of options and sell so little. Since they spent years getting to approval and pay is heavy on options cashing in a little is not meaningful, especially such a small percentage of available shares to sell.

Management has a huge stake, management clearly believes strongly this is a future BB drug, can't really argue against those two facts